Literature DB >> 18477769

Vascular dysfunction in a murine model of severe hemolysis.

Anne C Frei1, YiHe Guo, Deron W Jones, Kirkwood A Pritchard, Karen A Fagan, Neil Hogg, Nancy J Wandersee.   

Abstract

Spectrin is the backbone of the erythroid cytoskeleton; sph/sph mice have severe hereditary spherocytosis (HS) because of a mutation in the murine erythroid alpha-spectrin gene. sph/sph mice have a high incidence of thrombosis and infarction in multiple tissues, suggesting significant vascular dysfunction. In the current study, we provide evidence for both pulmonary and systemic vascular dysfunction in sph/sph mice. We found increased levels of soluble cell adhesion molecules in sph/sph mice, suggesting activation of the vascular endothelium. We hypothesized that plasma hemoglobin released by intravascular hemolysis initiates endothelial injury through nitric oxide (NO) scavenging and oxidative damage. Likewise, electron paramagnetic resonance spectroscopy showed that plasma hemoglobin is much greater in sph/sph mice. Moreover, plasma from sph/sph mice had significantly higher oxidative potential. Finally, xanthine oxidase, a potent superoxide generator, is decreased in subpopulations of liver hepatocytes and increased on liver endothelium in sph/sph mice. These results indicate that vasoregulation is abnormal, and NO-based vasoregulatory mechanisms particularly impaired, in sph/sph mice. Together, these data indicate that sph/sph mice with severe HS have increased plasma hemoglobin and NO scavenging capacity, likely contributing to aberrant vasoregulation and initiating oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477769      PMCID: PMC2442749          DOI: 10.1182/blood-2007-12-126714

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  59 in total

1.  Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction.

Authors:  Katherine C Wood; Robert P Hebbel; David J Lefer; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2006-01-17       Impact factor: 7.376

Review 2.  Emerging role of epoxyeicosatrienoic acids in coronary vascular function.

Authors:  B T Larsen; D D Gutterman; O A Hatoum
Journal:  Eur J Clin Invest       Date:  2006-05       Impact factor: 4.686

3.  Hemolysis-associated pulmonary hypertension in thalassemia.

Authors:  Claudia R Morris; Frans A Kuypers; Gregory J Kato; Lisa Lavrisha; Sandra Larkin; Titi Singer; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

4.  Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.

Authors:  Sylvia T Singer; Frans A Kuypers; Lori Styles; Elliott P Vichinsky; Drucella Foote; Howard Rosenfeld
Journal:  Am J Hematol       Date:  2006-09       Impact factor: 10.047

5.  Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function.

Authors:  R W Hagar; C R Morris; E P Vichinsky
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

6.  The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD.

Authors:  Shane A Phillips; O A Hatoum; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-13       Impact factor: 4.733

Review 7.  Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Stephen J Richards; Peter Hillmen
Journal:  Br J Haematol       Date:  2007-05       Impact factor: 6.998

8.  Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

Authors:  Lewis L Hsu; Hunter C Champion; Sally A Campbell-Lee; Trinity J Bivalacqua; Elizabeth A Manci; Bhalchandra A Diwan; Daniel M Schimel; Audrey E Cochard; Xunde Wang; Alan N Schechter; Constance T Noguchi; Mark T Gladwin
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

9.  Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome.

Authors:  C D Inward; A A Pall; D Adu; D V Milford; C M Taylor
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

10.  Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.

Authors:  Ersi Voskaridou; George Tsetsos; Antonios Tsoutsias; Evgenia Spyropoulou; Dimitrios Christoulas; Evangelos Terpos
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941

View more
  23 in total

1.  Pulmonary hypertension and NO in sickle cell.

Authors:  Mark T Gladwin; Robyn J Barst; Oswaldo L Castro; Victor R Gordeuk; Cheryl A Hillery; Gregory J Kato; Daniel B Kim-Shapiro; Roberto Machado; Claudia R Morris; Martin H Steinberg; Elliott P Vichinsky
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

2.  Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy.

Authors:  Jin Hyen Baek; Felice D'Agnillo; Florence Vallelian; Claudia P Pereira; Matthew C Williams; Yiping Jia; Dominik J Schaer; Paul W Buehler
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

3.  C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.

Authors:  J Fang; P Nurden; P North; A T Nurden; L M Du; N Valentin; D A Wilcox
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 4.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

Review 5.  Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).

Authors:  Bradley A Maron; Roberto F Machado; Larissa Shimoda
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 6.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

7.  Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.

Authors:  Tennille D Presley; Andreas S Perlegas; Lauren E Bain; Samir K Ballas; James S Nichols; Hernan Sabio; Mark T Gladwin; Gregory J Kato; Daniel B Kim-Shapiro
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

8.  Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.

Authors:  Kevin J Woollard; Sharelle Sturgeon; Jaye P F Chin-Dusting; Hatem H Salem; Shaun P Jackson
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

9.  Rapid conditional targeted ablation model for hemolytic anemia in the rat.

Authors:  Marina M Hanson; Fengming Liu; Shen Dai; Alison Kearns; Xuebin Qin; Elizabeth C Bryda
Journal:  Physiol Genomics       Date:  2016-07-01       Impact factor: 3.107

10.  Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.

Authors:  Bum-Yong Kang; Kathy Park; Jennifer M Kleinhenz; Tamara C Murphy; Roy L Sutliff; David Archer; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.